Cargando…
Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
Immunogenic cell death (ICD), a unique form of cancer cell death, has therapeutic potential in anti-tumour immunotherapy. The aim of this study is to explore the predictive potential of ICD in the prognosis and immunotherapy outcomes of glioblastoma multiforme (GBM). RNA sequencing data and clinical...
Autores principales: | Liu, Zhiye, Li, Wei, You, Guoliang, Hu, Zhihong, Liu, Yuji, Zheng, Niandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238813/ https://www.ncbi.nlm.nih.gov/pubmed/37273917 http://dx.doi.org/10.1515/med-2023-0716 |
Ejemplares similares
-
Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017) -
Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021) -
Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022) -
Tumor suppressive role of miR-194-5p in glioblastoma multiforme
por: Zhang, Zhao, et al.
Publicado: (2017) -
Cell-based immunotherapy of glioblastoma multiforme
por: Bryukhovetskiy, Igor
Publicado: (2022)